Active, Not Recruiting
A Randomized, Double-blind 2-arm, Followed by an Open-label 1-arm, NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome.
NCT05985915
- Conditions
- Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +15 more
- Locations
-
- Providence Medical Foundation Fullerton, California, United States
- Advanced Medical Research La Palma, California, United States
- Medvin Clinical Research Van Nuys, California, United States
- Bay Area Arthritis And Osteoporosis Brandon, Florida, United States